On-Site Medical Oxygen Generation Systems for Hospitals Market to Reach USD 3.18 Billion by 2032, as Hospitals Rebuild Oxygen Supply Around PSA Plants, Digital Monitoring and Backup Resilience

Global Reports Store today announced the release of its latest report, "On-Site Medical Oxygen Generation Systems for Hospitals Market Size, Healthcare Infrastructure Trends, Cost Optimization, Reliability Benchmarking & Forecast 2032." The March 2026 study, published under Report ID 1407, provides 425 pages of analysis covering technology type, capacity range, application, end user and region. The report estimates that the On-Site Medical Oxygen Generation Systems for Hospitals Market was valued at USD 1.64 billion in 2025 and is projected to reach USD 3.18 billion by 2032, expanding at a CAGR of 9.90% from 2026 to 2032.

Request For Exclusive Sample: https://www.globalreportsstore.com/request-sample/1407/

The message for hospital leaders is clear: oxygen generation is no longer only a biomedical engineering purchase. It is becoming core hospital infrastructure. The pandemic exposed how fragile cylinder and bulk-delivery models can become when transport, refilling, supplier coordination or regional demand spikes fail at the same time. The next phase of the market is being shaped by hospitals that want oxygen as a controlled utility, generated on-site, connected to pipeline supply, monitored digitally and backed by storage or cylinder-filling redundancy.

"Medical oxygen is a life-support resource, not a routine consumable," said a Global Reports Store spokesperson. "Hospitals are now looking at oxygen generation the way they look at power backup, water systems, infection-control systems and critical IT infrastructure. The strongest vendors will be those that can deliver not just a generator, but a complete oxygen platform with production, storage, alarms, purity tracking, maintenance visibility and backup continuity."

According to Global Reports Store, Pressure Swing Adsorption systems remained the largest technology category in 2025, generating USD 1.08 billion and accounting for 65.85% of total market revenue. PSA systems are projected to reach USD 2.05 billion by 2032, supported by their suitability for medium and large hospitals, medical gas pipelines, storage integration and cylinder-filling backup. Vacuum Pressure Swing Adsorption systems generated USD 0.24 billion in 2025, or 14.63% share, and are forecast to reach USD 0.49 billion by 2032. Membrane-based systems accounted for USD 0.17 billion, while hybrid oxygen generation systems generated USD 0.15 billion and are projected to reach USD 0.34 billion by 2032.

The capacity split shows where commercial demand is most concentrated. Systems in the 100 Nm3/h to 500 Nm3/h range generated USD 0.74 billion in 2025, representing 45.12% of the market, and are projected to reach USD 1.46 billion by 2032. This capacity range fits multi-specialty hospitals, regional hospitals and facilities with meaningful ICU, emergency and surgical oxygen demand. Below 100 Nm3/h systems generated USD 0.41 billion, while above 500 Nm3/h systems generated USD 0.49 billion and are expected to reach USD 0.99 billion by 2032, mainly serving tertiary hospitals, government referral centers and large medical campuses.

By application, central hospital oxygen supply remained the largest segment at USD 0.81 billion in 2025, equal to 49.39% of market revenue, and is projected to reach USD 1.60 billion by 2032. ICU and emergency care generated USD 0.31 billion, or 18.90% share, while surgical suites accounted for USD 0.22 billion. Neonatal and pediatric care generated USD 0.16 billion, and cylinder-filling backup integration represented USD 0.14 billion. This application mix shows that the market is moving beyond emergency procurement. Hospitals are now evaluating oxygen generation as a long-term clinical utility that supports daily operations and crisis readiness.

Regionally, North America led the market with USD 0.57 billion in 2025, representing 34.76% of global revenue, and is projected to reach USD 1.07 billion by 2032. The region's strength comes from hospital infrastructure spending, stronger adoption of digitally monitored facility systems and a growing focus on lifecycle cost control. Europe generated USD 0.45 billion, or 27.44% share, and is forecast to reach USD 0.88 billion by 2032. Asia-Pacific accounted for USD 0.40 billion, or 24.39% share, and is projected to reach USD 0.83 billion, supported by hospital expansion, public-sector oxygen planning and permanent oxygen infrastructure programs.

The policy backdrop is also shifting in favor of oxygen resilience. The World Health Assembly adopted a resolution on increasing access to medical oxygen in 2023, urging countries to assess medical oxygen access gaps at subnational and facility levels and improve availability of oxygen and related diagnostic and delivery devices. WHO's technical resource base also treats oxygen systems as an integrated ecosystem that includes production, storage, distribution, delivery devices and patient monitoring, rather than a single equipment purchase.

This matters because the biggest lesson from recent oxygen projects is not that hospitals need more equipment. It is that hospitals need systems that stay functional. Global Fund sustainability guidance for PSA plants emphasizes that PSA plants, supporting infrastructure and operations are only one part of a wider oxygen ecosystem, with sustainability depending on finance, energy, human resources, site planning and maintenance. Training material linked to PSA plant management also stresses daily and preventive maintenance, trained technical personnel and operational supervision.

One under-discussed trend is the change in the vendor sales model. Earlier purchases often centered on the oxygen generator skid. Today, hospitals increasingly want a full package: compressor, dryer, filtration, generator, storage, pipeline tie-in, cylinder filling, alarms, purity monitoring, maintenance logs, digital dashboards, spare parts and uptime support. Global Reports Store identifies hybrid systems with monitoring and backup integration as the fastest strategic opportunity, which reflects the movement from generator procurement to oxygen platform procurement.

UNICEF's Oxygen Plant-in-a-Box model also shows where deployment thinking is headed. UNICEF describes the package as a fully functional PSA oxygen plant that includes the equipment, accessories, installation, maintenance services and staff training needed to produce large volumes of medical-grade oxygen. The organization says the plants can be operational within days of arrival at a facility. This is important for hospital executives because it shows that future demand will reward configurable, deployment-ready systems rather than fragmented equipment purchases that require multiple vendors to coordinate after delivery.

The U.S. market still has a strong delivered-gas structure, but that structure also highlights why on-site generation is gaining board-level attention. Airgas, an Air Liquide company, says its U.S. medical oxygen supply network includes more than 1,400 locations and one of the industry's largest truck fleets. This scale is valuable, but it also confirms that medical oxygen has traditionally depended on physical logistics. On-site generation gives hospitals a different resilience option, especially where administrators want to reduce exposure to delivery scheduling, cylinder handling, transport cost and supplier concentration.

Japan's relevance is different. Japan has a mature hospital system, an aging population and strong medical gas suppliers, but the larger issue is disaster readiness and continuity of care. Japanese supplier Sumitomo Seika states that PSA oxygen generators can provide stable oxygen supply at lower cost than liquid oxygen, while Air Water describes oxygen and other medical gases as indispensable to medical treatments and also provides hospital operation, maintenance and medical-equipment services. These capabilities align with Japan's need for reliable medical infrastructure in a healthcare system exposed to aging demographics, disaster planning needs and high service expectations.

A hospital should not ask only whether an on-site oxygen plant can produce oxygen. It should ask whether the system can meet peak clinical demand, maintain stable purity, support pipeline pressure, integrate with existing medical gas infrastructure, provide backup cylinders or storage, alert facility teams before failure, and remain serviceable for years. This is why digital monitoring and lifecycle service contracts are becoming central to vendor differentiation.

Purchase This Exclusive Report: https://www.globalreportsstore.com/checkout/1407/

Key Developments

1. Global Reports Store identified hybrid systems with monitoring and backup integration as the fastest strategic opportunity. The report points to a clear market shift from generator-only purchases toward integrated oxygen platforms that combine production, storage, cylinder filling, alarms, purity control and backup continuity. This is the direction hospitals are likely to prioritize as they formalize oxygen resilience planning.

2. UNICEF's deployment model continued to shape oxygen plant procurement expectations. UNICEF's Oxygen Plant-in-a-Box approach shows that hospitals and public agencies increasingly value all-in-one PSA plant packages that include accessories, installation, maintenance and training, with plants designed to become operational quickly after arrival.

3. Sustainability and maintenance discipline became a central PSA plant issue. Global Fund-linked guidance emphasizes that sustainable PSA operation depends on more than procurement, including energy, finance, human resources, infrastructure and maintenance planning. This is directly changing how hospitals evaluate suppliers and service partners.

4. NOVAIR's ION oxygen generator strengthened the innovation narrative around on-site oxygen. NOVAIR's ION oxygen generator won the FHF Innovation Award in the Energy Transition category at SANTEXPO 2025. The company positioned the system around eliminating recurring gas deliveries, reducing logistics constraints and simplifying maintenance, reflecting the market's move toward lower-logistics oxygen production.

5. North American hospital oxygen supply remains logistics-heavy, creating a clear opportunity for on-site resilience. Airgas' U.S. network of more than 1,400 locations and large delivery fleet shows the strength of delivered medical oxygen infrastructure, but it also highlights why hospitals are evaluating on-site generation as a way to reduce delivery dependency and improve internal control over a critical clinical utility.

Global Reports Store believes the on-site medical oxygen generation systems for hospitals market is entering a more mature and strategically important phase. The strongest opportunities will not come from generic oxygen generator sales. They will come from systems that solve real hospital problems: oxygen security, ICU readiness, surgical continuity, neonatal safety, pipeline reliability, purity monitoring, backup integration, uptime assurance and long-term service economics.

For hospital leaders in the United States, Japan, Europe and Asia-Pacific, the decision is increasingly strategic. On-site medical oxygen generation is not only about reducing recurring gas purchases. It is about protecting clinical operations from external disruption, giving facility teams better control, and treating oxygen as a mission-critical hospital utility.

Media Contact
Global Reports Store
Office No. 301, Sairam IT Park, Hadapsar, Pune 411028
Email: sales@globalreportsstore.com
Phone: +91 8143002442

About Global Reports Store
Global Reports Store provides market intelligence designed for strategic decision makers across technology, energy, industrial, automotive and emerging-growth sectors. Its research supports leadership teams with data-driven analysis, competitive mapping, segmentation insight and country-level market interpretation for investment, product planning and partnership decisions.

This release was published on openPR.